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Structured Psychological Support for people with
personality disorder: feasibility randomised
controlled trial of a low-intensity intervention
Mike J. Crawford, Lavanya Thana, Jennie Parker, Oliver Turner, Aidan Carney, Mary McMurran, Paul Moran,
Timothy Weaver, Barbara Barrett, Sarah Roberts, Amy Claringbold, Paul Bassett, Rahil Sanatinia and
Amanda Spong
Background
National guidance cautions against low-intensity interventions
for people with personality disorder, but evidence from trials is
lacking.
Aims
To test the feasibility of conducting a randomised trial of a low-
intensity intervention for people with personality disorder.
Method
Single-blind, feasibility trial (trial registration: ISRCTN14994755).
We recruited people aged 18 or over with a clinical diagnosis of
personality disorder from mental health services, excluding
those with a coexisting organic or psychotic mental disorder. We
randomly allocated participants via a remote system on a 1:1
ratio to six to ten sessions of Structured Psychological Support
(SPS) or to treatment as usual. We assessed social functioning,
mental health, health-related quality of life, satisfaction with care
and resource use and costs at baseline and 24 weeks after
randomisation.
Results
A total of 63 participants were randomly assigned to either SPS
(n = 33) or treatment as usual (n = 30). Twenty-nine (88%) of those
in the active armof the trial received one ormore session (median
7). Among 46 (73%) who were followed up at 24 weeks, social
dysfunction was lower (−6.3, 95% CI −12.0 to −0.6, P = 0.03) and
satisfaction with care was higher (6.5, 95% CI 2.5 to 10.4; P =
0.002) in those allocated to SPS. Statistically significant differences
were not found in other outcomes. The cost of the intervention
was low and total costs over 24weekswere similar in both groups.
Conclusions
SPS may provide an effective low-intensity intervention for
people with personality disorder and should be tested in fully
powered clinical trials.
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Background
People with personality disorder have high levels of mental distress,
poor social functioning and reduced quality of life.1 One in 20
people have a personality disorder, and as many as half of people
in contact with secondary care mental health services meet diagnos-
tic criteria for the condition.2 No drugs are licensed for the treat-
ment of the disorder. However, a range of psychological therapies
have been developed that improve patient outcomes.3,4 Evidence-
based psychological treatments for people with personality disorder
are intensive and usually involve attending group-based therapy and
individual sessions over a 1- to 2-year period.3 Limited availability
of these treatments mean that many patients do not have access
to them, and those that do often face long waiting times before
they can start treatment.5 Even when these treatments are available,
some patients, such as those with coexisting substance dependence,
are excluded from them.6 Many patients are reluctant to attend
groups or are unable to make the commitment required to use
intensive treatment, and as many as half of people who are referred
to them do not engage with them.6 Levels of uptake may be even
lower among people from Black, Asian and minority ethnic
(BME) communities.6 As a result most people with personality dis-
order do not receive evidence-based psychological treatment.7
Intensity of treatment
Effective brief psychological treatments that do not require attend-
ance at groups have been developed for other mental health
conditions, such as anxiety, depression and psychosis. The develop-
ment of less intensive interventions for people with personality
disorder has been hampered by national guidelines for people
with borderline personality disorder that caution against the use
of interventions lasting less than 3 months.8 This recommendation
was based on clinical concerns about difficulties that many people
with personality disorder have with treatment endings and evidence
from a secondary analysis of data from a clinical trial of a brief inter-
vention following self-harm that found higher costs of care among
people with personality disorder in the active arm of the trial.9
Despite these concerns, services for people with personality dis-
order are under increasing pressure to treat more patients and
‘stepped care’ approaches have begun to be developed. In stepped
care all patients are initially offered a low-intensity intervention
and only those who do not respond are offered longer and more
intensive treatments.5,10,11 Low-intensity interventions are not
seen as a substitute for more intensive treatments, but rather an
approach that aims to increase access to appropriate care and
improve equity of access to more costly and intensive interventions.
Observational studies comparing the impact of lower- and
higher-intensity interventions for people with personality disorder
report similar outcomes.10 However, people are allocated to these
interventions on the basis of clinical factors that may affect progno-
sis, thus biasing estimates of treatment effect. Very few clinical trials
of low-intensity interventions for people with personality disorder
have been conducted.12 Those that have been conducted have
required people to attend therapy groups,13–15 examined adjunctive
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interventions designed to enhance the effects of longer-term psy-
chological treatments16,17 or have restricted recruitment to sub-
groups of patients with coexisting conditions.18
Structured Psychological Support
Structured Psychological Support (SPS) for personality and mental
health is a low-intensity intervention that was developed in collab-
oration with people with lived experience.19 It involves six to ten ses-
sions of individual psychoeducation and psychological support. SPS
is a person-centred approach that recognises the difficulties many
people with personality disorder have in trusting others.20 During
initial sessions, therapists work with patients to formulate a
shared understanding of the nature and aetiology of the person’s
presenting problems and agree on a focus for future sessions.
Drawing on techniques used in dialectical behaviour therapy, men-
talisation-based treatment and other higher-intensity psychological
treatments, therapists work to validate the patient’s experiences and
use one or more psychological approaches to help them with their
most pressing concerns. For many patients this involves trying to
find better ways to manage interpersonal problems and strengthen-
ing their capacity to tolerate emotional distress. Patients are given
self-help materials and information about other forms of commu-
nity support. Therapists are encouraged to use their experience of
what it is like to be with the patient to help guide their understand-
ing of the presenting problems.
Aims
In this paper, we report findings from a study investigating the feasi-
bility of conducting a randomised trial of SPS versus treatment as
usual (TAU) for people with personality disorder.
Method
Study design and participants
We conducted a two-arm, parallel group, researcher-masked,
randomised controlled trial with a 24-week follow-up assessment
(trial registration: ISRCTN14994755).18 We included a nested
qualitative study, to explore patient and provider beliefs about the
impact of the intervention, mechanisms of action and factors that
facilitate or hinder its successful delivery.
We recruited participants from community mental health teams
across three London boroughs. To take part in the study potential
participants had to be aged 18 or over, have a clinical diagnosis of
personality disorder and to have provided written informed
consent to participate in the study. Written informed consent was
obtained from all participants. After obtaining consent, participants
completed the Standardized Assessment of Severity of Personality
Disorder (SASPD).21 A score of eight or more on the SASPD pro-
vides a reliable assessment of the likelihood of personality disorder
according to ICD-11 criteria. We excluded people who scored less
than eight on the SASPD. We also excluded those who had a
coexisting diagnosis of an organic or psychotic mental disorder
(dementia, bipolar affective disorder, delusional disorder, schizo-
phrenia, schizoaffective disorder or schizotypal disorder), those
with cognitive or language difficulties that prevented them from
completing study assessments and those who were already receiving
psychological treatment for personality disorder.
The authors assert that all procedures contributing to this work
comply with the ethical standards of the relevant national and institu-
tional committees on human experimentation and with the Helsinki
Declaration of 1975, as revised in 2008. All procedures involving
patients were approved by the South Central Research Ethics
Committee (Ref 16/SW/0255) prior to the start of data collection.
Randomisation and masking
Study participants were randomly allocated to SPS or TAU in a
1:1 ratio using an independent web-based service ‘sealed envelope’
(https://www.sealedenvelope.com/simple-randomiser/v1/lists). We
stratified randomisation by gender and borough. The randomisation
list was encrypted and held in a trial coordinating office preventing
access by the research team. The trial manager informed patients,
therapists and clinical teams of the allocation status of participants.
This informationwas withheld from researchers who initiated all con-
versations with patients and staff with a reminder that they needed
to remain masked to the allocation arm of participants. When a
researcher was inadvertently unmasked arrangements were made
for an alternative researcher to undertake follow-up assessments.
Interventions
Those in the active arm of the trial were offered between six and ten
sessions of psychological support. SPS is a person-centred approach
that allows therapists to determine the exact number, frequency and
duration of sessions based on clinical judgement and patient prefer-
ence.19 During the first two sessions therapists assessed the patient’s
mental health, personality difficulties and existing understanding of
their problems and coping strategies in order to formulate a treat-
ment plan, including a crisis plan. By the end of session two, the
participant and the therapist aimed to agree on the focus for the
remaining sessions and share this in writing with the participant
and their general practitioner. The focus of the remaining sessions
depended on the needs and preferences of the participant but
included help with developing coping skills, support to better
understand problems in relationships or encouragement and
advice around the person’s social and occupational needs. It could
include advice and support to develop skills for emotional regula-
tion, distress tolerance or interpersonal effectiveness.22,23
During sessions the therapist discussed the nature of personality
disorder, what leads people to develop disturbed interpersonal func-
tioning and what steps people can take to lessen the impact that
aspects of their personality can have on their quality of life. SPS
draws on the two longer-term evidence-based treatments for
people with personality disorder: dialectical behaviour therapy
and mentalisation-based treatment. During sessions therapists
sought to validate the patient’s experience,24 and to promote men-
talising (the capacity to understand how mental states can affect a
person’s thoughts, feelings and actions and the thoughts, feelings
and actions of others).25
Therapists talked to patients about what healthcare services can
and cannot do to assist people with personality disorder and sup-
ported them to take steps to look after their mental health.
Therapists were encouraged to use a range of different methods
for communicating with patients according to their preferences,
including face-to-face meetings, telephone contacts, texts and
emails. Patients were given access to written and/or web-based
information and signposted to other services as appropriate. At
the end of the sessions participants were generally discharged
from secondary care services. This was made explicit to potential
participants before they enrolled in the study. However, therapists
were able to refer participants to longer-term psychological treat-
ments or continuing care from mental health services if it was
judged necessary to do so. Although there was variation in the
content and delivery of SPS, all therapists were asked to ensure
delivery of five key components:
(a) information about personality, personality disorder and the
role of health services;
(b) validation and radical acceptance aimed at reducing self-blame
and motivating self-efficacy;
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(c) psychological skill(s) for managing the main problem identi-
fied by the patient;
(d) discussion of the role of relationships and structured activities
in achieving better mental health;
(e) use of a ‘mentalising stance’ to highlight the importance of
mental states.
All staff delivering SPS were registered mental health profes-
sionals with experience of working with people with personality
disorder and had completed a 3-day basic training course in
mentalisation-based treatment. Staff were given a nine-page guide
on the organisation and content of SPS. Staff were asked to attend
fortnightly 75 min supervision meetings to discuss their case-load,
which was supervised by M.J.C.
Staff delivering SPS were asked to self-complete a proforma for
every participant that recorded the number and length of face-to-
face, telephone and email/text contacts they had with patients.
They were also asked to rate the extent to which they judged they
delivered five key components of SPS on a 10-point Likert scale
(where zero was not delivered, five was delivered and ten was
delivered in full).
TAU was delivered by staff working in community mental
health teams. This comprised assessment, care planning and
review. Those with coexisting mental health conditions and those
judged to be at high risk of severe self-harm may remain under
the care of mental health services for a longer period of time. As
part of the local care pathway for people with personality disorder,
staff discuss the time-limited nature of the service they provide from
the outset. Staff delivering TAU were able to refer participants to
longer-term psychological treatments in the usual way.
Measures
At baseline we collected demographic details and assessed eligibility
using the SASPD.21 Scores on the SASPD range from 0 to 27 with a
score of ≥8 indicating probable personality disorder. We also asked
participants to complete the International Personality Disorder
Examination Screening Questionnaire, a 77-item self-complete
questionnaire that provides a reliable indication of specific person-
ality disorders using DSM-IV criteria.26
Study participants were asked to complete the following
outcome measures at baseline and 6-month follow-up:
(a) the Work and Social Adjustment Scale (a short validated
assessment of social functioning);27
(b) the Warwick and Edinburgh Well-Being Schedule – a seven-
item questionnaire that provides a reliable assessment of
mental well-being;28
(c) suicidal thoughts using items from the National Household
Survey of Psychiatric Morbidity;29
(d) health-related quality of life using the three-level version of
EQ-5D (EQ-5D-3L), which is sensitive to change among
people with personality disorder;30
(e) satisfaction with care using the four-item Client Satisfaction
Questionnaire;31
(f) resource use and costs using a modified version of the Adult
Service Use Schedule;32
(g) participants were asked to rate any change in their mental
health during the previous 6 months using the Clinical
Global Impression Scale (CGI), a seven-point Likert scale
from very much improved to very much worse;33
(h) participants were asked to state how confident they are in their
ability to ‘get yourself through difficult times and situations’ on
a five-point Likert scale (ranging from totally confident to
totally unconfident). The psychometric properties of this
item have not been tested. It was included in the study
following feedback with stakeholders with lived experience of
personality disorder.19
All outcome measures were assessed again 24 weeks after ran-
domisation. Participants were offered a £20 honorarium for com-
pleting the 6-month follow-up interview. Researchers also asked
participants about adverse events during all contacts and scheduled
visits. All adverse events were recorded from consent until 30 days
after the final follow-up interview.
Collection of qualitative data
We also sought consent to conduct a qualitative interview with up to
20 participants (10 in each arm of the trial). These interviews were
conducted by a researcher with lived experience of using services for
people with personality disorder and took place after all quantitative
data had been collected. During this interview, participants were
asked about their experience of taking part in the study and any
steps they think we could take to improve the design of a future
definitive trial. The interview was semi-structured and guided by
a topic guide that was applied flexibly. Participants for the qualita-
tive component of the study were purposively selected to ensure that
men and women of different ages and ethnicities were selected from
those in both the active and control arm of the trial. We also held a
focus group with therapists who delivered SPS. We used a semi-
structured topic guide to ask therapists what worked well and less
well in the study and explore their views about SPS including the
role of the treatment guide, supervision sessions and if/how they
felt the intervention worked in practice.
Data analysis
In keeping with recommendations for feasibility studies, we did not
use a power calculation to determine the size of the study. Instead
we judged that a total sample of 60 participants would generate
sufficient data to assess the rate of recruitment and follow-up and
estimate levels of uptake and retention in therapy among those in
the active arm of the trial.
Our criteria for determining the success of the feasibility study
were: recruitment of at least 48 participants (80% of the target study
sample of 60 participants), uptake of SPS by at least 60% of partici-
pants in the active arm of the trial, and completion of follow-up
interviews at 6 months by 75% of study participants.
As a feasibility trial, the study was not powered to show statis-
tically significant differences between the two arms, hence the
primary analyses were descriptive in nature and was focused pri-
marily on characteristics of participants, attrition from the trial,
non-adherence to therapy and follow-up. Despite the lack of
formal powering, exploratory hypothesis tests were performed to
further compare study groups. The analyses were focused on the
outcomes measured on a continuous scale. Analyses were per-
formed for the outcomes at 6 months, and also for the change in
outcome from baseline to 6 months. All continuous outcomes
were found to be approximately normally distributed, and thus
the two-sample t-test was used for all analyses. The mean difference
in outcome between groups was reported, along with corresponding
95% confidence intervals. An additional analysis used the chi-
squared test to compare the proportion of patients with an improve-
ment on the CGI at 6 months.
The cost of the SPS intervention was calculated with data from
the treatment proformas completed by those delivering SPS and
costed using the approach set out by the Personal and Social
Services Research Unit.34 The cost of TAU was calculated for
both randomised groups by allocating a unit cost to all data items
that the participants received using data from the Adult Service
Use Schedule and nationally available unit costs.34
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Contemporaneous notes from qualitative interviews were made
during each interview and subjected to thematic analysis. We used
an inductive approach to analyse the data. The aim was to describe
the range of experiences and responses to the intervention, high-
lighting any patterns and divergences in respondent accounts that
support the key research questions relating to feasibility and accept-
ability of both the intervention and trial design.
Role of the funder
The funder of the study had no role in study design, data collection,
data analysis, data interpretation or writing of the report. The cor-
responding author had full access to all the data in the study and had
final responsibility for the decision to submit for publication.
Results
Between October 2017 and May 2018, 111 patients were referred to
the study. We were unable to make contact with 16 (14%) patients,
15 others declined to take part and 14 patients were ineligible
(Fig. 1). Of the 63 (57%) who met eligibility criteria and were
randomised, 33 were allocated to SPS and 30 to TAU. Six months
after randomisation 46 (73%) participants completed a follow-up
interview (24, 73% in the active arm of the trial and 22, 73% in
the TAU arm).
Table 1 summarises the baseline characteristics of participants
in the active and control arm of the trial. Study arms were well
balanced with the majority of participants in both arms being
women, unmarried and not in employment. Mean score on the
SASPD was 15.7, indicating moderate/severe personality
disorder.21
Participants in the active arm of the trial were collectively
offered a total of 252 sessions, and attended 204 (81%) of these.
In total, 29 (88%) participants, including 13 (72%) BME partici-
pants and 16 (88%) British White and White other participants,
attended one or more session of SPS (median 7, range 1–13).
Sessions generally lasted 50 min and took place on a weekly or fort-
nightly basis. Participants received an average of two telephone calls
lasting on average 9.4 min. All but five (15%) participants were dis-
charged to primary care after their treatment, with four continuing
to receive out-patient follow-up from community mental health
teams and one being referred to perinatal mental health services.
Ten therapists delivered the SPS (four mental health nurses,
three psychiatrists, two occupational therapists and one psychother-
apist). Record of activity forms were received for 27 (93%) of the 29
participants who attended one or more session of SPS. Therapists
rated that the five key components of SPS as having been delivered
for: information and discussion about personality, personality dis-
order and the role of health services in 25 patients (93%); validation
and radical acceptance in 23 (85%), psychological skills in 20 (74%);
discussion of the role of relationships and structured activities in
Referred to the study
n= 111  
Consented 
n= 66 
Declined, n= 15  
Unable to Contact, n = 16  
Ineligible, n = 14 (8 already 
receiving treatment, 5 
coexisting psychosis, 1 
unable to consent) 
Randomised 
n= 63 
Withdrew consent, n= 1  
Scored <8 on SASPD, n= 2  
Usual treatment (n= 30)
Received allocated intervention
(n= 30,100%) 
Psychological support (n= 33) 
Received intervention (n = 29, 87.9%) 
Did not received intervention (n = 4,12.1%) 
Lost to follow-up (n= 8, 26.7%) 
- unable to contact (n = 7)
- declined to take part (n= 1)
Lost to follow-up (n= 9, 27.3%)
- unable to contact (n= 8) 
- declined to take part (n= 1)
Analysed (n= 22, 73.3%)
- excluded from efficacy analysis
 (n= 0)
Analysed (n = 24, 72.7%)
- excluded from efficacy analysis (n = 0)
Fig. 1 Trial profile.
SASPD, Standardized Assessment of Severity of Personality Disorder
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achieving better mental health in 22 (82%); and use of a mentalising
stance for 21 (78%).
Baseline and 6-month follow-up scores on continuous study
outcomes are presented in Table 2. Levels of impairment in social
functioning were lower (mean difference−6.3, 95% CI −12.0 to
−0.6, P = 0.03) and levels of satisfaction with care were higher
(mean difference 6.5, 95% CI−2.5 to 10.4, P = 0.002) among those
allocated to SPS than those in the control arm of the trial. At
6-month follow-up 16 (67%) of 24 in the SPS arm of the trial
reported improvement on the CGI scale, compared with 10 (45%)
of 22 in the control arm of the trial (difference 21%, 95% CI−7%
to 49%, P = 0.15). High levels of suicidal ideation were reported
among participants in both arms of the trial at baseline and
follow-up with no differences between group (see Table 3).
Nine serious adverse events were recorded during the trial; all
were admissions to hospital for physical or mental health condi-
tions. In addition, seven other adverse events were recorded, one
of which (self-neglect following the end of active treatment) was
thought to be related to the trial. The cost of the SPS was on
average £360 per participant, of which £317 was the cost of the
one-to-one therapy and £67 was the cost of telephone calls. The
use and cost of medication, hospital and community services was
similar in both groups.
Qualitative data provided support for the role that SPS could
play in improving the mental health of people with personality
disorder. Participants who were offered active treatment felt it
was helpful to think about alternative ways of managing difficult
situations and considering the perspectives of others. Participants
also reported that they valued receiving one-to-one sessions and
being offered choices about the duration and frequency of sessions.
They reported receiving support that was non-judgemental.
However, some wanted to know more about the intervention
before it started and would have liked to have been given written
information. Some participants said that they would have liked to
have had further follow-up sessions with one stating the ten sessions
they received was ‘just not enough’ and another stating that the six
sessions they received did not ‘scratch the surface’. One participant
stated that they were concerned that the intervention was a ‘cost-
saving measure’ designed to ensure they were discharged from ser-
vices. Participants had a range of different experiences of therapists
that included feeling supported and listened to, whereas others
reported feeling dismissed and patronised.
Participants in the TAU arm of the trial expressed concerns
about what they were offered, including little contact with services
and long waiting times to access other sources of help.
Participants in both arms of the study liked the written communi-
cations they received from the study team and several thought
that it would have been helpful to have more frequent contact
with the study researchers. Most participants thought that study
questionnaires were easy to respond to and asked about things
that mattered to them, but two felt that the available responses
restricted what they wanted to say. Although participants said
that the process of randomisation had been explained to them,
many found the gap between completing the initial assessment
and finding out which group they had been allocated to was
anxiety-provoking and others questioned whether they really had
been allocated to interventions based on chance.
Nine of the ten therapists that delivered SPS took part in a
focus group, and one therapist took part in a semi-structured
interview. Staff delivering SPS spoke of their surprise at how
much ‘meaningful work’ it had been possible to do in a time-
limited number of sessions. Staff enjoyed having the flexibility of
the approach that had enabled them to deliver patient-centred
care and reported that it had been helpful to have a ‘buffet’ of
approaches and techniques they could draw on during the ses-
sions. Staff felt that it had been possible for them to manage
patient expectations about the short-term nature of the interven-
tion and highlighted the importance of group supervision as a
means of shared learning.
Discussion
Main findings
These results demonstrate that a randomised trial of SPS for person-
ality and mental health is entirely feasible. We were able to recruit to
target and levels of engagement in the active intervention were high.
We followed up 73% of the participants at 6 months, slightly fewer
than our 75% target.
The prevalence of personality disorder among people using
mental health services is high. The reluctance of many patients to
talk about their problems in groups and limited availability of
long-term therapies meant that clinicians found it easy to identify
potential participants. Entry criteria for the trial were broader
than those of high-intensity psychological treatments. We accepted
patients with coexisting alcohol and drug dependence who would
not have been considered suitable for group-based psychotherapy.
Because groups take place at regular times some patients with
work, child care or other regular commitments may be unable to
attend them. In contrast, therapists and patients were able to
Table 1 Patient demographics
Characteristic
Treatment
as usual
(n = 30)
Structured
Psychological
Support (n = 33)
Gender, n (%) 30 33
Female 21 (70) 22 (67)
Male 9 (30) 11 (33)
Age, years: mean (s.d.) 37.3 (13.5) 35.4 (9.8)
Marital status, n (%) 30 33
Single, never married 21 (70) 26 (79)
Married/partnership 4 (13) 2 (6)
Divorced 4 (13) 4 (12)
Widowed 1 (3) 1 (3)
Employment, n (%) 30 33
Employed for wages 6 (20) 6 (18)
Self-employed 0 (0) 2 (6)
Out of work, looking 1 (3) 3 (9)
Out of work, not looking 7 (23) 7 (21)
Homemaker 1 (3) 0 (0)
Student 2 (7) 2 (6)
Retired 1 (3) 0 (0)
Unable to work 12 (40) 13 (39)
Ethnicity, n (%) 29 33
White 16 (55) 18 (55)
Asian 0 (0) 2 (6)
Black 3 (10) 2 (6)
Mixed 5 (17) 6 (18)
Other 5 (17) 5 (15)
SASPD score, mean (s.d.) 16.2 (3.9) 15.2 (4.0)
IPDE criteria met, n (%) 30 33
Paranoid 26 (87) 26 (79)
Schizoid 24 (80) 23 (70)
Schizotypical 28 (93) 31 (94)
Histrionic 26 (87) 23 (70)
Antisocial 14 (47) 16 (48)
Narcissistic 15 (50) 17 (52)
Borderline 30 (100) 33 (100)
Compulsive 27 (90) 29 (88)
Dependent 23 (77) 27 (82)
Avoidant 26 (87) 31 (94)
SASPD, Standardized Assessment of Severity of Personality Disorder; IPDE, International
Personality Disorder Examination.
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schedule sessions of SPS around these commitments. As a result, we
found it easy to recruit to target. The main limit on the number of
people we could recruit was the availability of staff to deliver the
intervention.
Levels of uptake of SPS in the active arm of the trial were high,
with 29 (88%) attending one or more session and a median attend-
ance of seven sessions. There was greater representation of BME
patients in the study than among people taken on by local high-
intensity treatment services for people with personality disorder
by secondary care services. Ratings made by therapists delivering
SPS indicated that in over 70% of cases it was possible to deliver
the key components of the intervention within the number of
sessions that participants attended.
Quantitative data collected from study participants demon-
strated the potential of this low-intensity intervention to benefit
people with personality disorder. Although the study was not
powered to detect statistically significant differences in study out-
comes, those in the active arm of the trial reported a significant
improvement in social functioning and greater satisfaction with
care at the 6-month follow-up. Furthermore, although not statistic-
ally significant, the data also suggested that SPS has a potentially
positive impact on mental health and health-related quality of life.
The potential for the active intervention to improve social function-
ing among people with personality disorder is important because,
although most people with the condition report improved mental
health over time, impairment in social functioning is considered
to be an enduring feature of the condition.35 We estimate that the
cost of delivering the intervention was modest, but cost-effective-
ness remains to be tested.
Qualitative data from study participants provided additional
support for the benefits that some people with personality disorder
may gain from SPS. Study participants valued the choices they were
offered and the flexibility around the timing, frequency and content
of their sessions.
Study design
Our data also suggest ways that the design of the study could be
improved. Many of those who were allocated to TAU spoke of the
upset they experienced when they found out that they would not be
offered SPS. People in the TAU arm of the trial often felt unsupported
with the service they received. Resentful demoralisation associated with
allocation to control treatment is an issue in many clinical trials.36
Future trials of low-intensity interventions for people with personality
disorder should supplement TAU with some form of additional
support. This could help ensure that any differences seen in outcomes
are not influenced by the responses people may have to their allocation
status. Current national guidelines state that all people with borderline
personality disorder should be offered support to develop a crisis plan,8
but a recent national audit found that half of people did not have such
a plan.37 A clinical trial of jointly developed crisis plans with people
diagnosed with borderline personality disorder found that, although
many patients valued them, they did not lead to measurable changes
in patient outcomes.38 Hence, the addition of a session to develop a
joint crisis plan could ensure that all study participants receive add-
itional support while still enabling a valid assessment of any patient
benefit associated specifically with SPS.
Participants in the active arm of the trial told us that they would
have liked to have been given more information about SPS before
their first session. It would be a simple step to add an information
sheet for patients in advance of the start of SPS that could be dis-
cussed with the therapist at the start of the sessions.
People in the active arm of the trial also asked if it would be pos-
sible to have additional sessions of SPS. Although it would be
Table 2 Efficacy outcomes measured on a continuous scale
Outcome and time point
Treatment as
usual
Structured
Psychological
Support
Mean differencea (95% CI); P Effect size, Cohen’s d (95% CI)n Mean (s.d.) n Mean (s.d.)
WSAS
Baseline 30 29.3 (7.7) 33 28.0 (7.5) – –
Baselineb 22 29.9 (7.6) 24 28.4 (7.7) – –
6 months 22 30.9 (8.8) 24 24.6 (10.1) −6.3 (−12.0 to −0.6); 0.03 0.66 (0.07 to 1.28)
Changec 22 1.0 (6.3) 24 −3.8 (8.4) −4.8 (−9.3 to −0.4); 0.03 0.64 (0.05 to 1.24)
WEMWBS
Baseline 30 15.1 (4.6) 33 15.3 (3.8) – –
Baselineb 22 15.3 (4.4) 24 13.8 (3.8) – –
6 months 22 15.9 (4.7) 24 17.3 (5.5) 1.4 (−1.6 to 4.5); 0.36 0.27 (−0.31 to 0.85)
Changec 22 0.6 (5.0) 24 3.6 (5.2) 2.9 (−0.1 to 5.9); 0.06 0.58 (−0.01 to 1.17)
CSQ-8
Baseline 30 20.0 (5.8) 33 19.7 (6.0) – –
Baselineb 21 19.9 (5.7) 22 20.3 (5.2) – –
6 months 21 16.0 (5.7) 22 22.5 (6.9) 6.5 (2.5 to 10.4); 0.002 1.02 (0.39 to 1.67)
Changec 21 -3.8 (6.0) 22 2.2 (8.1) 6.0 (1.6 to 10.4); 0.008 0.84 (0.22 to 1.46)
ES-visual analogue scale (from the EQ-5D-3L)
Baseline 30 44.0 (24.0) 33 44.0 (16.0) – –
Baselineb 22 42.0 (21.0) 24 41.0 (17.0) – –
6 months 22 42.0 (26.0) 24 53.0 (26.0) 11 (−4.0 to 26.0); 0.16 0.42 (−0.16 to 1.01)
Changec 22 0.0 (22.0) 24 12.0 (22.0) 12 (−1.0 to 26.0); 0.07 0.55 (−0.04 to 1.13)
EQ-5D-3L
Baseline 30 0.20 (0.35) 32 0.26 (0.36) – –
Baselineb 22 0.13 (0.34) 23 0.27 (0.39) – –
6 months 22 0.23 (0.40) 23 0.36 (0.40) 0.13 (−0.10 to 0.37); 0.28 0.33 (−0.26 to 0.91)
Changec 22 0.10 (0.40) 23 0.12 (0.36) 0.02 (−2.1 to 0.25); 0.86 0.05 (−0.53 to 0.64)
WSAS, Work and Social Adjustment Scale; WEMWBS, Warwick and Edinburgh Well-Being Schedule; CSQ, Client Satisfaction Questionnaire; ED-VAS, ED visual analogue scale; ED-5D-3L,
three-level version of EQ-5D.
a. Difference calculated as value for Structured Psychological Support minus value for treatment as usual.
b. Summary statistics only for patients with values at 6 months.
c. Change calculated as value at 6 months minus value at baseline.
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possible to extend the number of sessions that patients are offered
this could undermine the rationale for this low-intensity interven-
tion. It is not unusual for people who are completing high-intensity
psychological interventions to want more time in treatment.6 For
people with long-term mental health conditions who can struggle
with endings, worries about the ability to cope without ongoing
support are well grounded. One of the core aims of many interven-
tions for people with personality disorder, including SPS, is to try to
help people develop greater self-confidence in coping with difficult
feelings and situations. Some psychological interventions include
a limited number of follow-up sessions in which people are able
to meet with a therapist sometime after regular treatment has
finished.39 Consideration could be given to adding one or more
top-up sessions to this intervention.
Limitations
Limitations of the study include length of follow-up, the level of
drop-out and the process used for assessing treatment fidelity.
Personality disorder is a long-term mental health condition and
it is therefore important to examine the long-term impact of inter-
ventions. The follow-up period in any explanatory trial of SPS
should therefore be longer than 6 months. The follow-up rate in
the trial was slightly lower than the 75% target. Further attention
would need to be paid to improving the rate of follow-up in a
future trial. Given feedback from study participants that they
would have liked additional contact with study researchers, add-
itional points of contact could be built into the protocol of a
future study.
We relied on self-ratings of therapists to explore the feasibility of
delivering SPS. The results of this exercise suggested that it was pos-
sible to deliver the key components of SPS within the available ses-
sions. Previous studies of psychological interventions for people
with personality disorder have examined treatment fidelity more
objectively by recording sessions and obtaining independent
ratings of treatment fidelity. Such an approach should be considered
in any full-scale trial of this intervention.
We did not use a formal diagnostic interview to confirm the
diagnosis of personality disorder in this trial. Such interviews are
lengthy, often taking an hour or more to complete. Data from a pre-
vious trial of problem-solving therapy for people with personality
disorder that used a structured diagnostic interview to assess eligi-
bility for trial inclusion found that nearly all those referred to the
trial (650, 95.3% of 682) met criteria for personality disorder,15
showing that clinicians referring to the trial were able to accurately
identify relevant patients. Time-consuming structured assessments
may, therefore, be unnecessary, particularly where the specific type
or types of personality disorder are not pertinent. With a mean
SASPD score of 15.7, participants in this trial had a level of severity
far in excess of the threshold for moderate personality disorder and
we can be confident that study participants would have had their
clinical diagnosis confirmed had they taken part in a lengthier
interview. Structured diagnostic interviews are not used in clinical
practice and may not be appropriate in the context of pragmatic
clinical trials that aim to generate knowledge that can be applied
in ‘real-world’ settings.
We do not know whether the benefits participants in the active
arm of the trial reported were the result of the specific factors
that make up SPS, or to non-specific factors related to time spent
with a therapist. However, the negative results of a recent, fully
powered, trial of problem-solving therapy for people with personal-
ity disorder suggest that time spent with therapists alone is not
sufficient to improve patient outcomes.15
This study was conducted in a secondary care mental health
setting, however, many people with personality disorder are
managed within primary care. Future research should examine
the acceptability and effectiveness of SPS delivered in primary
care settings.
Implications
The main implication of this study is that it is feasible to conduct a
clinical trial of SPS for people with personality disorder. A future
trial should be sufficiently large to assess minimum clinically
important differences between study arms. Consideration should
be given to providing study participants with more regular contact
with researchers and enhancing TAU for those in the control arm of
the trial. Should a low-intensity intervention such as SPS be found to
improve the health and social outcomes of people with personality
disorder it has the potential to be incorporated into a stepped-care
approach for people with this condition. This could lead to more
patients being offered evidence-based care than is currently the
case and high-intensity treatments being reserved for those who
most need them.
Table 3 Categorical outcomes
Category and time point
Treatment as usual
Structured
Psychological
Support
Total n
Outcome,
n (%) Total n
Outcome,
n (%)
Clinical Global Impression
Baseline 30 32
Very much improved 1 (3) 0 (0)
Much improved 7 (23) 4 (13)
Minimal improvement 4 (13) 10 (31)
No change 9 (30) 7 (22)
Minimally worse 3 (10) 2 (6)
Much worse 3 (10) 6 (19)
Very much worse 3 (10) 3 (9)
Baselinea 22 23
Very much improved 1 (5) 0 (0)
Much improved 4 (18) 3 (13)
Minimal improvement 3 (14) 5 (22)
No change 8 (36) 6 (26)
Minimally worse 1 (5) 2 (9)
Much worse 3 (14) 4 (17)
Very much worse 2 (9) 3 (13)
6 months 22 24
Very much improved 1 (5) 3 (13)
Much improved 1 (5) 7 (29)
Minimal improvement 8 (36) 6 (25)
No change 6 (27) 3 (13)
Minimally worse 0 (0) 2 (8)
Much worse 1 (5) 2 (8)
Very much worse 5 (23) 1 (4)
Suicidal behaviour
Felt life was not worth living
Baseline 30 21 (70) 33 18 (55)
Baselinea 22 16 (73) 24 14 (58)
6 months 22 14 (64) 24 13 (54)
Wished were dead
Baseline 30 21 (70) 33 18 (55)
Baselinea 22 15 (68) 24 13 (54)
6 months 22 13 (59) 24 14 (58)
Thought of taking own life
Baseline 30 17 (57) 33 17 (52)
Baselinea 22 12 (55) 24 13 (54)
6 months 22 10 (45) 23 12 (52)
Attempted to take own life
Baseline 30 2 (7) 33 0 (0)
Baselinea 22 2 (9) 24 0 (0)
6 months 22 1 (5) 24 1 (4)
a. Summary statistics only for patients with values at 6 months
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